BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19858129)

  • 1. Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gs{alpha} coding mutations and GNAS imprinting defects.
    Lecumberri B; Fernández-Rebollo E; Sentchordi L; Saavedra P; Bernal-Chico A; Pallardo LF; Bustos JM; Castaño L; de Santiago M; Hiort O; Pérez de Nanclares G; Bastepe M
    J Med Genet; 2010 Apr; 47(4):276-80. PubMed ID: 19858129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GNAS locus and pseudohypoparathyroidism.
    Bastepe M
    Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients.
    Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.
    Zazo C; Thiele S; Martín C; Fernandez-Rebollo E; Martinez-Indart L; Werner R; Garin I; ; Hiort O; Perez de Nanclares G
    J Bone Miner Res; 2011 Aug; 26(8):1864-70. PubMed ID: 21351142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNAS locus and pseudohypoparathyroidism.
    Bastepe M; Jüppner H
    Horm Res; 2005; 63(2):65-74. PubMed ID: 15711092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy.
    de Nanclares GP; Fernández-Rebollo E; Santin I; García-Cuartero B; Gaztambide S; Menéndez E; Morales MJ; Pombo M; Bilbao JR; Barros F; Zazo N; Ahrens W; Jüppner H; Hiort O; Castaño L; Bastepe M
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2370-3. PubMed ID: 17405843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations.
    Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B.
    Fernandez-Rebollo E; García-Cuartero B; Garin I; Largo C; Martínez F; Garcia-Lacalle C; Castaño L; Bastepe M; Pérez de Nanclares G
    J Clin Endocrinol Metab; 2010 Feb; 95(2):765-71. PubMed ID: 20008020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS.
    Bastepe M; Fröhlich LF; Hendy GN; Indridason OS; Josse RG; Koshiyama H; Körkkö J; Nakamoto JM; Rosenbloom AL; Slyper AH; Sugimoto T; Tsatsoulis A; Crawford JD; Jüppner H
    J Clin Invest; 2003 Oct; 112(8):1255-63. PubMed ID: 14561710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of two cases of pseudohypoparathyroidism (ia and ib) and molecular analysis of GNAS].
    Domínguez García A; Castaño González LA; Pérez-Nanclares G; Quinteiro González S; Caballero Fernández E
    An Pediatr (Barc); 2013 Nov; 79(5):319-24. PubMed ID: 23623851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification?
    Mantovani G; Elli FM; Spada A
    Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in GNAS epigenetic research of pseudohypoparathyroidism.
    Izzi B; Van Geet C; Freson K
    Curr Mol Med; 2012 Jun; 12(5):566-73. PubMed ID: 22300135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Definition of Pseudohypoparathyroidism Variants.
    Jüppner H
    J Clin Endocrinol Metab; 2021 May; 106(6):1541-1552. PubMed ID: 33529330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3.
    Elli FM; deSanctis L; Maffini MA; Bordogna P; Tessaris D; Pirelli A; Arosio M; Linglart A; Mantovani G
    Clin Epigenetics; 2019 Jan; 11(1):3. PubMed ID: 30616679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudohypoparathyroidism: one gene, several syndromes.
    Tafaj O; Jüppner H
    J Endocrinol Invest; 2017 Apr; 40(4):347-356. PubMed ID: 27995443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus.
    Jüppner H; Linglart A; Fröhlich LF; Bastepe M
    Ann N Y Acad Sci; 2006 Apr; 1068():250-5. PubMed ID: 16831926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paternal uniparental isodisomy of chromosome 20q--and the resulting changes in GNAS1 methylation--as a plausible cause of pseudohypoparathyroidism.
    Bastepe M; Lane AH; Jüppner H
    Am J Hum Genet; 2001 May; 68(5):1283-9. PubMed ID: 11294659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha.
    Mouallem M; Shaharabany M; Weintrob N; Shalitin S; Nagelberg N; Shapira H; Zadik Z; Farfel Z
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):233-9. PubMed ID: 17803690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib.
    Mantovani G; Bondioni S; Linglart A; Maghnie M; Cisternino M; Corbetta S; Lania AG; Beck-Peccoz P; Spada A
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3738-42. PubMed ID: 17595244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus.
    Bastepe M; Pincus JE; Sugimoto T; Tojo K; Kanatani M; Azuma Y; Kruse K; Rosenbloom AL; Koshiyama H; Jüppner H
    Hum Mol Genet; 2001 Jun; 10(12):1231-41. PubMed ID: 11406605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.